Stock NMTC NEUROONE MEDICAL TECHNOLOGIES CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases NeuroOne Medical Technologies Corporation

Equities

NMTC

US64130M2098

Real-time Estimate Cboe BZX
Other stock markets
 01:57:31 2024-05-23 pm EDT 		5-day change 1st Jan Change
1.07 USD +0.94% Intraday chart for NeuroOne Medical Technologies Corporation +1.07% -32.84%
May. 14 Transcript : NeuroOne Medical Technologies Corporation, Q2 2024 Earnings Call, May 14, 2024
Mar. 26 NeuroOne Medical Technologies Corporation Initiates Limited Commercial Launch of OneRF Ablation System CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
NeuroOne® Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
AQ
NeuroOne® to Report Second Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on May 14
AQ
NeuroOne® CEO Dave Rosa Featured on Bloomberg Technology
AQ
NeuroOne® Announces First Implant of OneRF™ Ablation Electrodes
AQ
NeuroOne® CEO Dave Rosa Featured on Fox Business Network’s Varney & Co.
AQ
NeuroOne® Initiates Limited Commercial Launch of OneRF™ Ablation System
AQ
NeuroOne to Participate in the 36th Annual Roth Conference
AQ
NeuroOne® to Participate in the 36th Annual Roth Conference
AQ
NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
AQ
NeuroOne® Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
AQ
NeuroOne® to Report First Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on February 13
AQ
NeuroOne® Reports Fiscal Fourth Quarter and Full Fiscal Year 2023 Financial Results and Provides Corporate Update
AQ
NeuroOne® Receives FDA 510(k) Clearance to Market its OneRF™ Ablation System
AQ
NeuroOne® to Report Fourth Quarter and Fiscal Year 2023 Financial Results and Provide Corporate Update on December 14
AQ
Thinking about buying stock in Adial Pharmaceuticals, Ares Capital Corp, SilverSun Technologies, Neuroone Medical Technologies, or enGene Holdings?
PR
NeuroOne® Announces Patent Allowance for Drug Delivery Utilizing a Novel Neural Probe
AQ
NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
AQ
NeuroOne® Provides Progress Update on FDA 510(k) Submission for OneRF™ Ablation System
AQ
NeuroOne® to Present at the ThinkEquity Conference on October 19, 2023
AQ
NeuroOne® to Present at the H.C. Wainwright 25th Annual Global Investment Conference
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NMTC Stock
  4. News NeuroOne Medical Technologies Corporation
  5. Press Releases